🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The #3TR team highlighted their research at #ECCO25! 🔬 In the poster exhibition, Florian Tran presented findings on shared immune pathways between #IBD and #RA, stressing the value of cross-disease studies in advancing our understanding of chronic inflammation! #3TR #IBD #ECCO25

Our #3TR stories continue in 2025! This series highlights young researchers, and today we’re featuring Charisios Triantafyllou from GENYO! He tells us about his research on #SLE and explains what fascinates him about his work in the #3TR project. Read more 👉 3tr-imi.eu/news-and-media…

Next in our #3TR story is Katrien Quintelier from the VIB - UGent unit at SaeysLab. 🧪 💻 She shares insights on handling batch effects and integrating patient data from different centres. Read more👉 tinyurl.com/3ysud5ch

On this World Young Rheumatic Diseases Day, let's raise awareness that rheumatic diseases can affect people of all ages, including children and young adults. Let’s advocate for better support, and ensure no young person faces this journey alone.💪✨ #3TR #RA #WORDDay2025

Exciting discussions at today's #3TR Joint Steering Committee Meeting in Basel, Switzerland! We reviewed our project’s progress, assessed the current status, and mapped out the next steps!📈✅ #3TR #Basel #MS #SLE #RA #IBD #asthma #COPD

Huge congratulations to Kate Khaleva from the University of Southampton for completing her PhD and leading this impactful international study on severe asthma as part of the #3TR project! 🎓👏

New on the #3TR website: our section on patient-reported outcomes (PROs) is now live! 🎉💻 💡Discover why #PROs matter in improving patient care and how 3TR is contributing to this vital field. 🔗 Explore more here: 3tr-imi.eu/research/patie… #3TR #PatientCentredCare #PROs

Following the launch of our new #3TR website section on #PROs, we’re excited to share the first interview! Dr Graham Roberts, Professor at University of Southampton, explains why PROs are key to developing better therapies for #asthma. 💡 Watch the interview here: 3tr-imi.eu/research/patie…

On #WorldAsthmaDay we highlight the importance of patient voices in research. A study by University of Southampton within #3TR contributed to this effort by developing the first patient-centred scoring system to assess severe asthma treatment responses. Learn more: southamptonbrc.nihr.ac.uk/post/new-scori…

🎙 On #WorldAsthmaDay, #3TR patient representative Theo Schilpzand, who lives with severe #asthma, shares his perspective on how Patient Reported Outcomes (PROs) are key to developing treatments that truly meet patient needs. ▶️ Watch the full video here: 3tr-imi.eu/research/patie…

Great way to wrap up #DDW2025 with Kiel's strong participation! Congrats to the team! 👏

Great work! Florian Tran 👏

🚨Job alert! 🔎We're looking for a Front-End Software Engineer Join us and contribute to key projects in cancer, rare diseases, and immunology, such as Instand-NGS4P or 3TR-IMI 🗓️Deadline: 31 May 📥Applications: cnag.eu/jobs/front-end… #JobAlert #FrontendEngineer #SoftwareJobs

#Lupus affects millions but is often misunderstood. On #WorldLupusDay, #3TR unites to #MakeLupusVisible. Blanca Rubio, Lupus Europe patient representative, discusses how #PROs can transform care and improve treatment. 👉 Watch: 3tr-imi.eu/research/patie…

On #WorldIBDDay 2025, we're uniting to break #taboos about IBD. 💜 At #3TR, we study 7 autoimmune, inflammatory & allergic diseases – including #CrohnsDisease & #UlcerativeColitis. Today, we highlight other IBD research efforts by our partners – driving change together. 🤝💡

On #WorldIBDDay2025, we’re amplifying patient voices on IBD and continuing our #PROs series. Bastien Corsat, #3TR Patient Advisory Committee member with #Crohns, shares how patient-reported outcomes support the patient perspective in research and care. ▶️ 3tr-imi.eu/research/patie…

🎥 In today’s #PROs episode, Francesca Marchiori from Lupus Europe reflects on 30+ years living with lupus – and why patient-reported outcomes matter. At #3TR, we belive it is important to highlight patients’ real-life experiences. 👉 Watch the interview: 3tr-imi.eu/research/patie…

Happy faces at today's #3TR Joint Steering Committee Meeting at the GSK Medicines Research Centre in Stevenage, UK, where we reviewed project progress, and planned next steps. It was great meeting everyone in person!👏 #3TR #ImmuneMediatedDiseases #SLE #RA #IBD #asthma #COPD

🌍 This #WorldMSDay, we stand with the MS community and support better, earlier diagnosis – in line with this year's theme #MyMSDiagnosis 💙 At #3TR, we study MS alongside 6 other immune diseases to understand shared mechanisms and improve treatment for all. 🔬🧬 #MS #3TR

In our latest #PROs interview, Ioannis Parodis, senior consultant rheumatologist & professor at Karolinska Institutet, explains why patient-reported outcomes matter in clinical practice and #3TR research. Watch the full video here: 3tr-imi.eu/research/patie… #PatientCentredCare #Lupus